Moreover, downregulating chemokines and their receptors can decrease the inflammatory responses induced by obesity, prevent the onset of insulin resistance, and facilitate the upregulation of mitochondrial oxidative phosphorylation and fatty acid metabolism pathways, for example, in brown adipocytes as seen with CCL5 [16,17]. This evidence concerns the gene CCL5 and obesity disorder.